What is Bio Protocol?
Bio Protocol is a decentralized science (DeSci) platform that coordinates funding, IP ownership, and data sharing for biotech research through a network of specialized bioDAOs. Each bioDAO focuses on a specific disease or research area—e.g., HairDAO for alopecia, VitaDAO for longevity—and Bio Protocol is the shared infrastructure layer that connects them. The native token is BIO. The protocol raised over $33 million from investors including Pfizer Ventures and a16z crypto before its token went live in early 2025.
The AI angle comes from a specific thesis: biological research generates enormous datasets that are currently siloed inside universities and pharma companies. Bio Protocol proposes to unlock that data by tokenizing IP and data ownership, letting bioDAOs pool it, and then making it accessible to AI training pipelines in exchange for BIO-denominated fees. That positions BIO at the intersection of two of the most hyped narratives in crypto—DeSci and AI—simultaneously.
BIO price today
The BIO price is determined by spot trading on centralized and decentralized exchanges. Live data refreshes every 60 seconds on this page. The reference price is a volume-weighted average across the venues with the deepest BIO order books.
Key drivers for BIO price:
- DeSci narrative momentum. BIO trades alongside other DeSci tokens. VitaDAO milestones, bioDAO fundraising announcements, and pharma partnership news move the whole sector.
- AI data demand signals. Enterprise demand for proprietary biological datasets—for drug discovery AI, genomics models—raises the perceived value of what Bio Protocol's IP marketplace could eventually deliver.
- Ecosystem bioDAO activity. The number of active bioDAOs, IP-NFT auctions completed, and research milestones unlocking token tranches all influence near-term price.
- BTC and altcoin correlation. BIO trades as a small-cap altcoin and amplifies broad market moves. Check market overview for sector context.
The discussion below uses prices at page load.
How Bio Protocol works: bioDAOs and IP-NFTs
The core primitive is the IP-NFT, a non-fungible token that represents ownership rights over a piece of biotech intellectual property—a research dataset, a compound patent, a clinical protocol. Researchers mint IP-NFTs to fund their work; bioDAOs hold them in their treasuries, which gives DAO members governance rights over how the IP is licensed and monetized.
Bio Protocol adds a coordination layer on top. BIO is the meta-governance token: holders vote on which bioDAOs are recognized within the ecosystem and eligible for BIO liquidity mining incentives. New bioDAOs apply to the protocol, propose their focus area, and go through a community vote. Approved DAOs receive BIO emissions to bootstrap their own token liquidity.
The AI data angle works like this: once IP-NFTs are aggregated inside a bioDAO treasury, the DAO can license access to those datasets to AI companies under terms voted on by token holders. Revenue flows back into the treasury. The promise is a feedback loop where data licensing revenue funds more research, which creates more IP-NFTs, which attract more AI buyers.
BIO tokenomics and DeSci ecosystem
BIO launched with a total supply of 3.35 billion tokens. Allocation includes ecosystem/DAO treasury, team (with vesting), investors, and community incentives including airdrops to existing VitaDAO and HairDAO participants who had demonstrated engagement before BIO launched. The investor base—Pfizer Ventures, a16z crypto, Shine Capital—is notable because it includes traditional life sciences capital alongside crypto-native funds, which is unusual and relevant to the thesis.
Key ecosystem bioDAOs at launch:
- VitaDAO — longevity research, one of the oldest and largest DeSci DAOs with published research and real IP portfolios.
- HairDAO — alopecia and hair loss research, funded multiple academic labs.
- AthenaDAO — women's reproductive health.
- PsyDAO — psychedelic-assisted therapy research.
- ValleyDAO — synthetic biology for climate tech.
Bio Protocol vs VitaDAO: how they relate
VitaDAO is the oldest and best-known DeSci project, founded in 2021. It focuses specifically on longevity research and has its own token, VITA. Bio Protocol is not a competitor to VitaDAO—it is the shared infrastructure layer that VitaDAO (and other bioDAOs) plugs into. Think of Bio Protocol as the TCP/IP layer and VitaDAO as an application built on top.
BIO holders can participate in governance across all bioDAOs in the ecosystem, while VITA holders govern only the VitaDAO-specific portfolio. For investors, BIO offers broader exposure to the DeSci sector with less concentration in any single disease area.
For AI-adjacent tokens in the same cycle, see Fetch.ai price and our exchange ratings for trading venue comparison.
AI and biotech data labeling on-chain
The data labeling vertical is where Bio Protocol's AI narrative becomes concrete. Biological data—genomic sequences, protein structures, pathology images, clinical trial outputs—requires expert annotation before it is useful for training AI models. Annotating one genomic dataset can cost millions of dollars if routed through traditional CROs (contract research organizations).
Bio Protocol's roadmap includes a marketplace where researchers and bioDAOs can post labeling tasks, and contributors—domain-expert crowds or AI-assisted tools—earn BIO for verified annotations. That connects the token to a real workflow with real costs that pharma and biotech companies currently pay to centralized vendors.
How to buy Bio Protocol (BIO)
- Select an exchange that lists BIO. Binance, OKX, Bybit, and Gate.io are the primary venues. Our exchange ratings compare fees, security, and geographic availability.
- Complete KYC and fund your account. USDT deposits settle fastest. For self-custody, set up a MetaMask or Rabby wallet before withdrawing.
- Execute the trade. BIO/USDT pairs carry the most liquidity. Limit orders minimize slippage during low-volume hours.
- Consider where BIO lives on-chain. The token exists on Ethereum mainnet and Base. Gas fees on mainnet favor larger trade sizes; Base is cheaper for smaller amounts.
- If you plan to participate in bioDAO governance, move BIO to a self-custody wallet and familiarize yourself with snapshot.org voting tools used by the ecosystem.
For longer-range price targets tied to DeSci adoption milestones, see the Bio Protocol price forecast.
Risks of holding Bio Protocol
BIO is a small-cap token at the intersection of two early-stage sectors. The risks compound.
- Research timeline risk. Drug discovery takes 10-15 years even under ideal conditions. Token prices price in success years before it happens. Most IP funded by bioDAOs will not produce commercial returns in a typical crypto investment horizon.
- Regulatory uncertainty for IP-NFTs. Tokenized intellectual property is legally novel in most jurisdictions. Enforcement of IP-NFT rights in traditional courts has not been tested at scale.
- Pharma partnership execution. BIO is priced partly on the thesis that big pharma will license data from bioDAOs. Actual deals are slow and subject to procurement rules, legal review, and data-room standards that DAOs are still learning to meet.
- DeSci narrative dependency. Like other niche-narrative tokens, BIO can trade 80%+ below peak when the sector falls out of rotation, regardless of research progress. Compare to AI token volatility for reference.
- Liquidity risk. BIO is a small-cap token with relatively thin order books outside the top one or two venues. Large exits can move price materially.
- Team and investor unlock schedules. Track vesting calendars for team and investor allocations before entering a large position.
This page is information, not financial advice. Consult a licensed professional before investing.
Bio Protocol's all-time high of $0.888995 was set on January 3, 2025. The current price sits +96.88% below that peak. Distance from the all-time high is a common reference point when evaluating long recoveries and macro support or resistance.
Buying Bio Protocol (BIO) is a five-step routine once you have picked the right venue and pair. The steps below mirror what most investors do today.
Whether Bio Protocol is a good investment depends on your goals, time horizon, and tolerance for volatility. Like all cryptocurrencies, BIO carries real market risk: prices can rise or fall sharply in a day, and past performance is not a reliable indicator of future returns.
This page provides data and analysis for educational purposes only. It is not financial advice. Always do your own research, diversify, and never invest more than you can afford to lose.
